Design and synthesis of novel 2-substituted 11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agents with Pin1 inhibition ability
- 1 January 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 126, 910-919
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273360)
This publication has 38 references indexed in Scilit:
- Nine triterpenes from Boswellia sacra Flückiger and their chemotaxonomic importanceBiochemical Systematics and Ecology, 2013
- Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugsNatural Product Reports, 2012
- Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkersInternational Journal of Cancer, 2011
- Acetyl-11-Keto-β-Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2–Mediated AngiogenesisCancer Research, 2009
- Boswellic acids: a group of medicinally important compoundsNatural Product Reports, 2008
- Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disordersPhytomedicine, 2008
- Acetyl‐keto‐β‐boswellic acid inhibits cellular proliferation through a p21‐dependent pathway in colon cancer cellsBritish Journal of Pharmacology, 2006
- Acetyl-11-Keto-β-Boswellic Acid Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis by Suppressing NF-κB and NF-κB-Regulated Gene ExpressionThe Journal of Immunology, 2006
- Cancer Chemopreventive Effects and Cytotoxic Activities of the Triterpene Acids from the Resin of Boswellia carteriBiological and Pharmaceutical Bulletin, 2006
- Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cellsCarcinogenesis, 2002